Nisa Investment Advisors LLC Trims Stock Position in The Clorox Company (NYSE:CLX)

Nisa Investment Advisors LLC trimmed its holdings in The Clorox Company (NYSE:CLXFree Report) by 9.8% during the third quarter, Holdings Channel reports. The institutional investor owned 26,368 shares of the company’s stock after selling 2,875 shares during the period. Nisa Investment Advisors LLC’s holdings in Clorox were worth $4,296,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CLX. Innealta Capital LLC purchased a new position in shares of Clorox in the 2nd quarter worth $30,000. Trifecta Capital Advisors LLC increased its position in Clorox by 139.8% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after purchasing an additional 130 shares in the last quarter. First Foundation Advisors purchased a new position in Clorox in the first quarter valued at approximately $31,000. Family Firm Inc. purchased a new position in Clorox in the second quarter valued at approximately $31,000. Finally, Quarry LP lifted its position in Clorox by 99.1% during the second quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after buying an additional 114 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Analyst Ratings Changes

CLX has been the subject of several recent research reports. TD Cowen assumed coverage on shares of Clorox in a research report on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 price objective for the company. Citigroup increased their price target on Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a report on Friday, September 6th. Barclays raised their price objective on Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a research report on Friday. Deutsche Bank Aktiengesellschaft upped their target price on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. Finally, Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and raised their target price for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. Six equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat, Clorox currently has a consensus rating of “Hold” and a consensus target price of $150.29.

Read Our Latest Research Report on CLX

Insider Activity at Clorox

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the transaction, the executive vice president now owns 13,471 shares of the company’s stock, valued at $2,229,719.92. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. Corporate insiders own 0.57% of the company’s stock.

Clorox Stock Up 2.9 %

Shares of NYSE:CLX opened at $163.12 on Friday. The firm has a market cap of $20.20 billion, a PE ratio of 56.84, a price-to-earnings-growth ratio of 3.12 and a beta of 0.41. The company has a fifty day simple moving average of $161.48 and a 200 day simple moving average of $146.14. The company has a current ratio of 1.03, a quick ratio of 0.63 and a debt-to-equity ratio of 5.04. The Clorox Company has a 12-month low of $121.76 and a 12-month high of $169.09.

Clorox (NYSE:CLXGet Free Report) last issued its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. The business had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 292.08%. The company’s revenue for the quarter was up 27.0% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.49 EPS. On average, equities research analysts anticipate that The Clorox Company will post 6.64 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be issued a $1.22 dividend. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.99%. Clorox’s dividend payout ratio (DPR) is 170.04%.

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.